RBC Capital raised the firm’s price target on Oxford Biomedica (OXBDF) to 930 GBp from 800 GBp and keeps an Outperform rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXBDF:
- Oxford Biomedica Director’s Share Transaction Error and Resolution
- Oxford Biomedica Announces New Share Admission on LSE
- Oxford Biomedica’s Chair Increases Stake with Significant Share Purchase
- Oxford Biomedica Raises £60 Million to Expand US Operations
- Oxford Biomedica Announces £60 Million Equity Raise to Expand Global CDMO Network